跳至主要内容
临床试验/ACTRN12613000706774
ACTRN12613000706774招募中未知

Does undercarboxylated osteocalcin contribute to improved insulin sensitivity following exercise in overweight and obese men?

Victoria University0 个研究点目标入组 12 人开始时间: 2013年6月28日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
40 Years 至 70 Years(—)
性别
Male

入选标准

  • Age: 40-70 years.
  • BMI: 25-40 kg/m^2.
  • patients with type 2 diabetes will be permitted to participate if they are treated with diet alone.

排除标准

  • Men with bone disease (such as osteoporosis)
  • Men who are taking any prescribed medication known to affect bone metabolism, insulin secretion or insulin sensitivity.
  • Musculoskeletal or orthopaedic condition (such as severe osteoarthritis) that prevents normal daily function (such as walking).
  • Men with symptomatic or uncontrolled metabolic or cardiovascular disease
  • warfarin therapy or vitamin K supplementation or restriction

研究者

相似试验